Detalles de la búsqueda
1.
Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study.
Clin Cancer Res
; 22(6): 1378-84, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26644410
2.
Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.
Oncologist
; 9(6): 687-95, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15561812
Resultados
1 -
2
de 2
1
Próxima >
>>